Combination spirometer-inhaler

Information

  • Patent Grant
  • 12029844
  • Patent Number
    12,029,844
  • Date Filed
    Wednesday, June 23, 2021
    3 years ago
  • Date Issued
    Tuesday, July 9, 2024
    4 months ago
  • Inventors
  • Original Assignees
    • Willow Laboratories, Inc. (Irvine, CA, US)
  • Examiners
    • Murphy; Victoria
    Agents
    • Knobbe, Martens, Olson & Bear, LLP
Abstract
Various spirometer-inhaler systems and devices are disclosed. The spirometer-inhaler system may estimate physiological parameters of a user based on the user's inhaled and/or exhaled breaths received by the spirometer-inhaler device. The spirometer-inhaler device may comprise one or more flow paths. A first flow path may direct medication from a medicine canister to an opening of the device. A second flow path may direct a user's exhaled breath from the opening of the device to one or more flow measurement devices.
Description
FIELD OF THE DISCLOSURE

The general field of this disclosure is systems and devices related to managing a user's respiratory condition.


BACKGROUND

Spirometers are often used to diagnose a variety of chronic lung conditions, such as asthma and chronic obstructive pulmonary disease (“COPD”), that may require the use of control and rescue inhalers. To complete a spirometer maneuver, many current spirometers require a user to attempt to use full tidal volume of their lungs and blow through a wide hole. Such a maneuver can result in coughing and general discomfort. Additionally, treatment of chronic lung conditions may require users carry around a number of items, including rescue medication, control medication, inhaler, spirometer, and a tracking device.


SUMMARY

In some aspects of the disclosure, a spirometer-inhaler device for managing a user's respiratory condition is disclosed. A spirometer-inhaler device can include: a first portion that can removably receive a medicine canister; a second portion that can extend from the first portion and include a mouthpiece; a first flow path that can direct medication from the medicine canister to the opening of the mouthpiece; and a second flow path that can direct exhaled air from the opening of the mouthpiece to one or more flow rate measurement devices. The mouthpiece can include an opening and one or more propellers. The second flow path can include one of the one or more propellers.


In some aspects, the first portion can include a central cavity that can removably receive the medicine canister.


In some aspects, the first portion can optionally include a one way valve that can removably connect to the medicine canister and direct medication from the medicine canister to the opening of the mouthpiece.


In some aspects, the first flow path can include the one way valve and the opening of the mouthpiece.


In some aspects, the one way valve can form a seal with the medicine canister.


In some aspects, the seal can prevent the exhaled air from entering the first flow path.


In some aspects, the one way valve can deliver the medication from the medicine canister to the opening of the mouthpiece via the first flow path.


In some aspects, the first portion may not include a valve. For example, the first portion may include an interior gap that can direct medication from the medicine canister to the opening of the mouthpiece.


In some aspects, the spirometer-inhaler device can further include an interior flow pathway with a first end and a second end.


In some aspects, the second flow path can include the interior flow pathway and the opening of the mouthpiece.


In some aspects, the first end of the interior flow pathway can be located adjacent the opening of the mouthpiece. The second end of the interior flow pathway can be located on a side portion of the first portion.


In some aspects, the second flow path can further include at least one cover.


In some aspects, the at least one cover can include at least one shutter. The at least one shutter can include a lever portion and a cover portion that can cover the second end of the interior flow pathway.


In some aspects, the cover portion of the at least one shutter can be removed from the second end of the interior flow pathway in response to a user actuating the lever portion of the at least one shutter.


In some aspects, the at least one cover can include one or more of: a manual plug, a rotatable cover, a mechanical iris, or a cuspid one-way valve.


In some aspects, the interior flow pathway can include an interior tube.


In some aspects, the interior flow pathway can include a plurality of interior ribs. The plurality of interior ribs can guide the second flow path from the opening of the mouthpiece to the second end of the plurality of interior ribs.


In some aspects, the second end of the interior flow pathway can removably connect to the one or more flow rate measurement devices.


In some aspects, the spirometer-inhaler device can further include a display.


In some aspects, the display can be disposed on the first portion.


In some aspects, the spirometer-inhaler can further include at least one processor that can estimate one or more physiological parameters of the user based on measurements from the device.


In some aspects, the spirometer-inhaler device can further include a transmitter.


In some aspects, the transmitter can transmit the one or more physiological parameters of the user to one or more of: a network, a backend system, or one or more user devices.


In some aspects, the first flow path can include a propeller of the one or more propellers.


In some aspects, the propeller can be positioned adjacent the opening of the mouthpiece.


In some aspects, the propeller can spin in response to a negative flow rate within the mouthpiece.


In some aspects, the at least one processor can begin taking measurements in response to the propeller spinning.


In some aspects, the negative flow rate can be created within the mouthpiece by the user inhaling from the opening of the mouthpiece in use.


In some aspects, a propeller of the one or more propellers can be operatively connected to a turbine.


In some aspects of the disclosure, a system for delivering a medication to a user and measuring a plurality of physiological parameters of the user is disclosed. The system can include: a spirometer-inhaler device; a medicine canister that can deliver the medication to a first portion of the spirometer-inhaler device; and one or more measurement devices that can estimate one or more physiological parameters of the user. The spirometer-device can include: the first portion that can removably receive the medicine canister; a second portion that can extend from the first portion and include a mouthpiece that can include an opening and one or more propellers; a first flow path that can direct the medication from the medicine canister to the opening of the mouthpiece; and a second flow path that can direct exhaled air from the opening of the mouthpiece to one or more flow rate measurement devices. The second flow path can include one of the one or more propellers. The one or more measurement devices can include the one or more flow rate measurement devices.


In some aspects, the spirometer-inhaler device can further include a central hole that can removably receive the medicine canister.


In some aspects, the spirometer-inhaler device can further include a one way valve that can removably connect to the medicine canister and direct medication from the medicine canister to the opening of the mouthpiece.


In some aspects, the medicine canister can deliver the medication to the one way valve.


In some aspects, the first flow path can include the one way valve and the opening of the mouthpiece.


In some aspects, the central hole of the first portion can include an internal gap. The internal gap can direct medication from the medicine canister to the opening of the mouthpiece.


In some aspects, the spirometer-inhaler device can further include an interior flow pathway with a first end and a second end.


In some aspects, the first end of the interior flow pathway can be located adjacent the opening of the second portion and the second end of the interior flow pathway can be located on a side portion of the first portion.


In some aspects, the second flow path can include the interior flow pathway and the opening of the mouthpiece.


In some aspects, the second end of the interior flow pathway can be connectable to the one or more flow rate measurement devices.


In some aspects, the interior flow pathway can include one or more of: one or more interior tubes or one or more interior ribs.


In some aspects, the one or more flow rate measurement devices can estimate at least one of: forced inspiratory flow, force expiratory volume, forced expiratory flow, force vital capacity, maximal voluntary ventilation, inspiratory reserve volume, expiratory reserve volume, residual volume, functional residual capacity, total lung capacity, inspiratory capacity, tidal volume, vital capacity, maximal inspiratory pressure, or maximal expiratory pressure.


In some aspects, the one or more flow rate measurement devices can be connectable to the second flow path.


In some aspects, the one or more measurement devices can measure at least one of: oxygen saturation, respiratory rate, total hemoglobin level, level of carboxyhemoglobin, level of methemoglobin, pulse rate, or acoustic measurements.


In some aspects, the system can further include a display.


In some aspects, the display can be disposed on one or more of: the spirometer-inhaler device, the one or more measurement devices, or one or more user devices.


In some aspects, the system can further include a transmitter.


In some aspects, the transmitter can transmit the one or more physiological parameters of the user to one or more of: a network, a backend system, or one or more user devices.





BRIEF DESCRIPTION OF THE DRAWINGS

The following drawings and the associated descriptions are provided to illustrate embodiments of the present disclosure and do not limit the scope of the claims.



FIG. 1 illustrates a block diagram of an example use environment for a spirometer-inhaler device.



FIGS. 2-3 illustrate perspective views of a spirometer-inhaler device.



FIG. 4 illustrates a close up view of a component of a spirometer-inhaler device.



FIG. 5 illustrates an exploded view the spirometer-inhaler device shown in FIGS. 2-3.





DETAILED DESCRIPTION

Aspects of the disclosure will now be set forth in detail with respect to the figures and various examples. One of skill in the art will appreciate, however, that other configurations of the devices and methods disclosed herein will still fall within the scope of this disclosure even if not described in the same detail. Aspects of various configurations discussed do not limit the scope of the disclosure herein, which is instead defined by the claims following this description.



FIG. 1 illustrates an example use environment 400 that may make practical use of the health management systems, including a spirometer-inhaler device 100, described herein. For example, in the illustrated environment 400, one or more data collection devices 404 may collect data associated with a user 402. The data collection devices 404 may include the spirometer-inhaler device 100, as further described below with reference to FIGS. 2-4, one or more physiological sensors, one or more flow measurement devices, or other devices that may be used to monitor the health of the user. For example, the data collection devices 404 may include any device that may be used to monitor the respiratory health of the user. Example sensors may include optical heart rate sensors, electrical heart rate sensors accelerometers and gyroscopes, a GPS radio, temperature sensors, spectroscopic instruments, and/or other sensors. These example sensors may, for example, be used to take ECG readings, measure blood analytes, measure a user's movement, detect that a user is falling, or detect the user's position. Example devices may include measurement devices that measure one or more of: oxygen saturation, respiration rate, total hemoglobin levels, carboxyhemoglobin levels, methemoglobin levels, pulse-rate, pulse-rate variability, perfusion, Pleth variability index (PVI), pulmonary vascular resistance, and a variety of acoustic measurements. The spirometer-inhaler device 100 and the one or more data collection devices 404 may communicate with a backend system 410 through a network 408. Additionally or alternatively, the spirometer-inhaler device 100 and the one or more data collection devices 404 may communicate with one or more user devices 406. The user device 406 may include smart phones, tablet computers, laptop computers, smart watches, other mobile and wearable devices, desktop computers, networked televisions, networked game consoles, and/or the like. The device could also include a 3G/4G/5G modem for direct connection to the cloud to prevent the need for a smart phone. For example, the device 100 may measure a user's Forced Inspiratory Flow (FIF) value and display the user's FIF value on the user's smart phone or other electronic device. The one or more user devices 406 may communicate with the backend system 410 through a network 408.


The one or more user devices 406 can include a device associated with the user 402 of the one or more data collection devices 404, a device associated with a health care provider, a device associated with a third-party user, a device associated with a user's employer, the like or a combination thereof. For example, a user may measure the user's FIF value with the spirometer-inhaler device 100 and the spirometer-inhaler device 100 may transmit the user's estimated FIF value to the health care provider's device(s) so that the health care provider can monitor the user's respiratory health. Additionally, or alternatively, the device 100 can communicate the user's FIF value to the user's phone to display the user's FIF value on the phone's display and store the FIF value in the phone's memory so that the user can monitor the user's own respiratory health. For example, the user may download a mobile application associated with the spirometer-inhaler device 100 onto the user's phone or smartwatch. In order to access the user's respiratory health data, the user may access the mobile application and view the different physiological parameters being measured by the device 100 or the spirometer-inhaler system 200, as described below in reference to FIGS. 2-5. Moreover, in some embodiments, the device 100 can communicate the user's FIF value to the network 408. A user 402 and a health care provider may have respective login information to access the network 408 to monitor the user's 402 FIF values or other physiological parameters. In some examples, the one or more user devices 406 may upload, download, stream, display, analyze, read, write, access, or otherwise interact with data associated with the user 402, such as the data collected by the one or more data collection devices 404, data stored in the backend system 410 or other remote, non-local storage location, or data locally stored on the user devices 406. In some examples, the backend system 410 can include one or more hardware processors and/or storage systems capable of upload, download, display, analyze, read, write, access, or otherwise interact with the data or information associated with the user or other information associated with displaying and/or analyzing the data or information associated with the user.


The data collected by the spirometer-inhaler device 100, and the one or more data collection devices 404 can include a plurality of data associated with the user, including but not limited to health data. In some examples, health data can include heart rate, blood pressure, glucose, VO2 maximum, oxygen saturation, respiration rate, total hemoglobin levels, carboxyhemoglobin levels, methemoglobin levels, pulse-rate, pulmonary vascular resistance, symptoms and their severity, FIF, Force Expiratory Volume (FEV1), Forced Expiratory Flow (FEF), the like or a combination thereof. This collected data can be processed in a variety of different ways. For example, the spirometer-inhaler device 100 may include a processor that estimates a user's FIF value based on the user blowing into the device 100. The spirometer-inhaler device 100 may store the FIF data on a memory of the device 100 and display the FIF value on a display of the device 100. Additionally, or alternatively, the device 100 may send a measured value to a second device or the backend system 410, which processes the measured value to estimate a FIF value. The second device may display the estimated FIF value or the second device may send the FIF value to the device 100 so that the device 100 displays the FIF value.



FIGS. 2-5 illustrate different views of a spirometer-inhaler system 200 that can be used in the use environment 400 described in reference to FIG. 1. For example, the spirometer-inhaler system 200 may include a spirometer-inhaler device 100, a canister 300 configured to removably connect to the spirometer-inhaler device 100, one or more flow measurement devices (not shown) configured to removably connect to the spirometer-inhaler device 100, and/or one or more processors. The spirometer-inhaler system 200 may combine the assessment ability of a spirometer with the ability to deliver medication of an inhaler. Medication can include, for example, control medication or rescue medication associated with a respiratory disease, such as asthma.


In some aspects, the spirometer-inhaler device 100 may include a first portion 110 and a second portion 112. In some embodiments, the device 100 may include a general L-shape, similar to a standard inhaler, with the first portion 110 forming the vertical component and the second portion 112 forming the horizontal component. Although the device 100 is shown as including a general L-shape, other shapes are contemplated. For example, the device may be cylindrical, conical, spherical, or have another shape in whole or in part. The first portion 110 may include a one-way valve 120, a first end 122 including a top opening, and a central cavity. The central cavity of the first portion 110 can extend from the first end 122 through the center of the first portion 110 and be configured to removably receive the canister 300. In some aspects, the first portion 110 itself can be one of the two (or more) channels required for flow estimations. The first portion 110 can have a one-way valve 120 (such as illustrated in FIGS. 4 and 5) to improve the simplicity of the device 100. In some aspects, the one-way valve 120 may be configured to removably connect with the canister 300. For example, the one-way valve 120 may include a threaded recess configured to engage with a threading on an end of the canister 300 such that the end of the canister 300 can be sealed to the one-way valve 120 while a body portion of the canister 300 can be housed within the central cavity of the first portion 110. Additionally or alternatively, the canister 300 may removably connect to the one-way valve 120 with a snap-fit engagement, detent, or other coupling mechanism. The canister 300 may form a seal with the one-way valve 120 so as to prevent a user's expiratory flow from traveling via a first flow path 106 of the system 200, as described below. The one-way valve 120 may be configured to allow fluid to flow from the canister 300 to an opening 114 of the second portion 112 and prevent fluid from flowing in the opposite direction. In some examples, the second portion 112 can include at least a portion of the first flow path 106. In addition to, or alternative to, the one-way valve 120, the first portion 110 can include an internal gap or aperture within the central cavity of the first portion 110 adapted to allow fluid to flow from the canister 300 to the opening 114 of the second portion 112 and prevent fluid from flowing in the opposite direction.


In some aspects, the second portion 112 of the device 100 may extend from the first portion 110, adjacent a second end 126 of the first portion 110 opposite the first end 122. The second portion 112 may include a mouth piece 112 with an opening 114 and at least one propeller 116, 118. In some embodiments, the system 200 may include a turbine with a turning wheel. In some embodiments, the system 200 includes the canister 300. The canister 300 may be a medicine canister that holds control medication, rescue medication, or the like.


In some configurations, the disclosed system 200 can include two or more flow paths 104, 106. A first flow path 106 of the two or more flow paths may include the canister 300, the one-way valve 120 of the first portion 110, and/or the second portion 112. The direction of the first flow path 106 is indicated by arrow 106 in FIG. 2. The one-way valve 120 can be configured to direct medication from the canister 300 along the first flow path 106 to the user during inhalation while preventing the user's exhaled breaths from traveling along the first flow path 106. The second portion 112 may optionally include a first propeller 118 positioned in the first flow path 106 adjacent to the opening 114 of the second portion 112. The first propeller 118 may be configured to better deliver the medication into the user's lungs. For example, when a user places the mouthpiece 112 in the user's mouth and inhales to administer the medication, a negative flow rate is created that may cause the first propeller 118 to spin and propel the medication from the canister 300 into the user's mouth. Additionally or alternatively, the first propeller 118 spinning can notify the one or more processors of the system 200 that the medication is being administered and the one or more processors of the system 200 can detect how much of the medication was administered and the depth of the user's breath. For example, the one or more processors of the system 200 may be configured to measure the amount of medication administered and the depth of the user's inhaled breath when the first propeller 118 begins spinning. The measured depth of the user's inhaled breath can be used as another variable to estimate various physiological parameters of the user.


In some configurations, the spirometer-inhaler system 200 can take additional measurements to enable better predictive capacity of FEV1 or FEF. For example, the system 200 can utilize the patient's inhalation to better estimate common respiratory measurements. Moreover, the system 200 can use additional measurements, such as oxygen saturation, respiration rate, and the like, to improve the estimation of all variable types listed in the present disclosure. For example, these additional measurements can be utilized as spot-check, trended, or modeled forms of these data types.


In some configurations, the system 200 includes a second flow path 104 that may include portions of the second portion 120. The direction of the second flow path 104 is indicated by arrow 104 in FIGS. 2 and 3. The second portion 120 may further include an interior flow pathway 124 and a second propeller 116. The system 200 is configured to direct the user's exhaled breaths along the second flow path 104. For example, referring to FIGS. 4 and 5, a user may exhale into the opening 114 and the user's exhaled breath is directed through the interior flow pathway 124. For example, the interior flow pathway 124 can comprise one or more tubes or one or more ribs adapted to guide the second flow path 104. A first end 128 of the interior flow pathway 124 can be positioned adjacent the opening 114 and the second propeller 116. A second end 130 of the interior flow pathway 124 can be positioned on a side portion of the first portion 110, adjacent the second end 126 of the first portion 110. Although the first and second ends 128, 130 of the interior flow pathway 124 are illustrated in this manner, the first and second ends 128, 130 may be located anywhere on the device 100 that allows for at least two flow paths 104, 106.


In some aspects, the second end 130 of the interior flow pathway 124 is configured to be removably connected to the one or more flow measurement devices. The one or more flow measurement devices can include devices that measure FT values, FEV1 values or FEF values. When the one or more flow measurement devices are connected to the interior flow pathway 124, the second flow path 104 may include the one of the one or more flow measurement devices.


The interior flow pathway 124 may include a hole, which extends from the first end 128 of the interior flow pathway 124 to the second end 130 of the interior flow pathway 124, that may be smaller than the wider standard holes of current spirometers. For example, the hole of the interior flow pathway 124 can be approximately half to a quarter of the size of the wider standard holes of current spirometers.


As described above, the system 200 can comprise one or more processors. The processor(s) may be located within the spirometer-inhaler device 100, the one or more flow measurement devices, and/or the backend system 410. In some embodiments, the processor(s) can be configured to extrapolate the measurements from the smaller hole of the interior flow pathway 124 to assess the air flow of the wider standard holes of current spirometers. The smaller hole enables the prediction of FIF, FEV1 or FEF without requiring the user to completely expel the air (or completely deplete the air) from their lungs. Advantageously, reducing the amount of lung depletion may improve user comfort. In some configurations, the processor may also be configured to upload, download, display, analyze, read, write, access, or otherwise interact with the data or information associated with the user, such as data collected by the one or more data collection device 404 including the device 100 and/or the one or more flow measurement devices, or other information associated with displaying and/or analyzing the data or information associated with the user.


Additionally or alternatively, the one or more processors of the system 200 may estimate biometric parameters other than FIF, FEV1, or FEF, including, but not limited to, Force Vital Capacity (FVC), Maximal Voluntary Ventilation (MVV), Inspiratory Reserve Volume (IRV), Expiratory Reserve Volume (ERV), Residual Volume (RV), Functional Residual Capacity (FRC), Total Lung Capacity (TLC), IC (Inspiratory Capacity), tidal volume, vital capacity, and Maximal Inspiratory Pressure (MIP), and Maximal Expiratory Pressure (MEP). To effectively estimate some of these other values, the user may have to deplete their lungs.


In some aspects, the second flow path 104 may include a turbine with a first end and a second end. The first end of the turbine can include a turning wheel that can be adapted to cause the airflow that passes through the turning wheel to rotate helically. The turbine can also include a vane between the turning wheel and the second end of the turbine. The helically rotating airflow can cause the internal vane to rotate. The rotations of the internal vane can be detected by a sensor which can send the sensor signals to the one or more processors. The processor(s) can determine certain physiological parameters related to a patient's lung functionality. For example, the processor(s) can determine a user's FIF, FEV1 and/or FEF values.


In some embodiments, the system 200 may comprise a memory configured to store user's instructions. For example, one or more processors of the system 200 may access the user's instructions from the memory and display the instructions on a display of the system 200. The user's instructions may instruct the user on how to measure different physiological parameters with the system 200. For example, if the user wants to measure the user's FVC value, the user's instructions may include instructing the user to deplete the user's lungs into the device 100. Additionally or alternatively, the user can access the user's instructions on the user's phone via the mobile application associated with the spirometer-inhaler device 100. In some aspects, the user can access the user's instructions on any of the user devices 406 via an application, a website, or the like.


In some configurations, the spirometer-inhaler system 200 may further include a display (not shown) configured to display relevant information, one or more sensors, a battery, and a transmitter. In some aspects, the display can be positioned on the spirometer-inhaler device 100 and be electronically connected to the battery and the one or more processors. Additionally or alternatively, the display may be positioned on the one or more user devices 406 and/or the one or more flow measurement devices. For example, when a user blows into the device 100, the display can show the estimated FIF value. In some embodiments, the device 100 may include one or more sensors that can be electronically connected to the one or more processors and the battery. Additionally or alternatively, the one or more sensors may be located within the one or more flow measurement devices. The one or more sensors may include one or more differential pressure sensors.


In some configurations, the transmitter that can be electronically connected to the battery and the one or more processors. Additionally or alternatively, the transmitter may be located within the one or more flow measurement devices. In some aspects, the transmitter may be configured to transmit the health data from the device 100 or the one or more flow measurement devices to the network 408, the back end system 410, and/or the one or more user devices 406.


In some embodiments, one or more covers 108 may be incorporated in the second flow path 104 to enable switching between the one or more flow measurement devices. For example, the one or more covers 108 can include one or more shutters 108 with a lever portion 132 connected to a cover portion 134 configured to cover the second end 130 of the interior flow pathway 124. The user can push on the lever portion 132 removing the cover portion 134 from the second end 130 of the interior flow pathway 124, thereby opening the second flow path 104. With the second flow path 104 open, the user can removably connect an external device to the second flow path 104. The external device, for example, can include the one or more flow measurement devices. Additionally, or alternatively, the one or more covers 108 may include a manual plug, a cover adapted to open and close via a rotation mechanism, a mechanical iris, a cuspid one-way valve, a flap, or the like.


Terminology

Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain, certain features, elements and/or steps are optional. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required or that one or more implementations necessarily include logic for deciding, with or without other input or prompting, whether these features, elements and/or steps are included or are to be always performed. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list.


Conjunctive language such as the phrase “at least one of X, Y, and Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to convey that an item, term, etc. may be either X, Y, or Z. Thus, such conjunctive language is not generally intended to imply that certain implementations require the presence of at least one of X, at least one of Y, and at least one of Z.


Language of degree used herein, such as the terms “approximately,” “about,” “generally,” and “substantially” as used herein represent a value, amount, or characteristic close to the stated value, amount, or characteristic that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount. As another example, in certain implementations, the terms “generally parallel” and “substantially parallel” refer to a value, amount, or characteristic that departs from exactly parallel by less than or equal to 15 degrees, 10 degrees, 5 degrees, 3 degrees, 1 degree, 0.1 degree, or otherwise.


Any methods disclosed herein need not be performed in the order recited. The methods disclosed herein include certain actions taken by a practitioner; however, they can also include any third-party instruction of those actions, either expressly or by implication.


The methods and tasks described herein may be performed and fully automated by a computer system. The computer system may, in some cases, include multiple distinct computers or computing devices (for example, physical servers, workstations, storage arrays, cloud computing resources, etc.) that communicate and interoperate over a network to perform the described functions. Each such computing device typically includes a processor (or multiple processors) that executes program instructions or modules stored in a memory or other non-transitory computer-readable storage medium or device (for example, solid state storage devices, disk drives, etc.). The various functions disclosed herein may be embodied in such program instructions, and/or may be implemented in application-specific circuitry (for example, ASICs or FPGAs) of the computer system. Where the computer system includes multiple computing devices, these devices may, but need not, be co-located. The results of the disclosed methods and tasks may be persistently stored by transforming physical storage devices, such as solid state memory chips and/or magnetic disks, into a different state. The computer system may be a cloud-based computing system whose processing resources are shared by multiple distinct business entities or other users.


Depending on the implementation, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (for example, not all described operations or events are necessary for the practice of the algorithm). Moreover, in certain implementations, operations or events can be performed concurrently, for example, through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially.


The various illustrative logical blocks, modules, routines, and algorithm steps described in connection with the disclosure herein can be implemented as electronic hardware (for example, ASICs or FPGA devices), computer software that runs on general purpose computer hardware, or combinations of both. Various illustrative components, blocks, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as specialized hardware versus software running on general-purpose hardware depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.


Moreover, the various illustrative logical blocks and modules described in connection with the disclosure herein can be implemented or performed by a machine, such as a general purpose processor device, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor device can be a microprocessor, but in the alternative, the processor device can be a controller, microcontroller, or state machine, combinations of the same, or the like. A processor device can include electrical circuitry configured to process computer-executable instructions. A processor device can include an FPGA or other programmable device that performs logic operations without processing computer-executable instructions. A processor device can also be implemented as a combination of computing devices, for example, a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. Although described herein primarily with respect to digital technology, a processor device may also include primarily analog components. For example, some or all of the rendering techniques described herein may be implemented in analog circuitry or mixed analog and digital circuitry. A computing environment can include any type of computer system, including, but not limited to, a computer system based on a microprocessor, a mainframe computer, a digital signal processor, a portable computing device, a device controller, or a computational engine within an appliance, to name a few.


The elements of a method, process, routine, or algorithm described in connection with the disclosure herein can be embodied directly in hardware, in a software module executed by a processor device, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of a non-transitory computer-readable storage medium. An exemplary storage medium can be coupled to the processor device such that the processor device can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor device. The processor device and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor device and the storage medium can reside as discrete components in a user terminal.


While the above detailed description has shown, described, and pointed out novel features, it can be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As can be recognized, certain portions of the description herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. The scope of certain implementations disclosed herein is indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A system for delivering a medication to a user and measuring one or more physiological parameters of the user, the system comprising: a spirometer-inhaler device comprising: a first portion configured to removably receive a medicine canister;a second portion extending from the first portion, the second portion comprising a mouthpiece, wherein the mouthpiece comprises an opening and a plurality of propellors;a first flow path configured to direct a medication from the medicine canister to the opening of the mouthpiece, wherein the first flow path comprises a first propellor of the plurality of propellors adjacent the opening; anda second flow path configured to direct exhaled air from the opening of the mouthpiece to one or more flow rate measurement devices, wherein the second flow path comprises a second propellor of the plurality of propellors adjacent the opening;the medication canister configured to deliver the medication to the first portion of the spirometer-inhaler device; andone or more measurement devices configured to estimate one or more physiological parameters of the user, the one or more measurement devices comprising the one or more flow rate measurement devices.
  • 2. The system of claim 1, wherein the spirometer-inhaler device further comprises a central hole configured to removably receive the medicine canister.
  • 3. The system of claim 2, wherein the spirometer-inhaler device further comprises a one way valve configured to removably connect to the medicine canister and to direct the medication from the medicine canister to the opening of the mouthpiece.
  • 4. The system of claim 3, wherein the medicine canister is configured to deliver the medication to the one way valve.
  • 5. The system of claim 3, wherein the first flow path comprises the one way valve and the opening of the mouthpiece.
  • 6. The system of claim 2, wherein the central hole comprises an internal gap configured to direct the medication from the medicine canister to the opening of the mouthpiece.
  • 7. The system of claim 1, wherein the spirometer-inhaler device further comprises an interior flow pathway with a first end and a second end.
  • 8. The system of claim 7, wherein the first end of the interior flow pathway is located adjacent the opening of the mouthpiece, wherein the second end of the interior flow pathway is located on a side portion of the first portion.
  • 9. The system of claim 8, wherein the second flow path comprises the interior flow pathway and the opening of the mouthpiece.
  • 10. The system of claim 9, wherein the second end of the interior flow pathway is configured to be connectable to the one or more flow rate measurement devices.
  • 11. The system of claim 7, wherein the interior flow pathway includes one or more of: one or more interior tubes or one or more interior ribs.
  • 12. The system of claim 1, wherein the one or more flow rate measurement devices are configured to estimate at least one of: forced inspiratory flow, forced expiratory volume, forced expiratory flow, forced vital capacity, maximal voluntary ventilation, inspiratory reserve volume, expiratory reserve volume, residual volume, functional residual capacity, total lung capacity, inspiratory capacity, tidal volume, vital capacity, maximal inspiratory pressure, or maximal expiratory pressure.
  • 13. The system of claim 1, wherein the one or more flow rate measurement devices are configured to be connectable to the second flow path.
  • 14. The system of claim 1, wherein the one or more measurement devices are configured to measure at least one of: oxygen saturation, respiratory rate, total hemoglobin level, level of carboxyhemoglobin, level of methemoglobin, pulse rate, or acoustic measurements.
  • 15. The system of claim 1, further comprising a display.
  • 16. The system of claim 15, wherein the display is disposed on one or more of: the spirometer-inhaler device, the one or more measurement devices, or one or more user devices.
  • 17. The system of claim 1, further comprising a transmitter.
  • 18. The spirometer-inhaler device of claim 17 wherein the transmitter is configured to transmit the one or more physiological parameters of the user to one or more of: a network, a backend system, or one or more user devices.
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application claims the benefit of priority to U.S. Provisional App. No. 63/044,269 entitled “COMBINATION SPIROMETER-INHALER,” filed Jun. 25, 2020 and U.S. Provisional App. No. 63/071,310 entitled “COMBINATION SPIROMETER-INHALER,” filed Aug. 27, 2020. Each of these applications are hereby incorporated by reference herein in their entireties. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference and made a part of the present disclosure.

US Referenced Citations (540)
Number Name Date Kind
492973 Shepard Mar 1893 A
895606 Warde Aug 1908 A
4148308 Sayer Apr 1979 A
4960128 Gordon et al. Oct 1990 A
4964408 Hink et al. Oct 1990 A
5319355 Russek Jun 1994 A
5337744 Branigan Aug 1994 A
5341805 Stavridi et al. Aug 1994 A
D353195 Savage et al. Dec 1994 S
D353196 Savage et al. Dec 1994 S
5377676 Vari et al. Jan 1995 A
D359546 Savage et al. Jun 1995 S
5431170 Mathews Jul 1995 A
5436499 Namavar et al. Jul 1995 A
D361840 Savage et al. Aug 1995 S
D362063 Savage et al. Sep 1995 S
D363120 Savage et al. Oct 1995 S
5456252 Vari et al. Oct 1995 A
5479934 Imran Jan 1996 A
5482036 Diab et al. Jan 1996 A
5494043 O'Sullivan et al. Feb 1996 A
5533511 Kaspari et al. Jul 1996 A
5561275 Savage et al. Oct 1996 A
5590649 Caro et al. Jan 1997 A
5602924 Durand et al. Feb 1997 A
5638816 Kiani-Azarbayjany et al. Jun 1997 A
5638818 Diab et al. Jun 1997 A
5645440 Tobler et al. Jul 1997 A
5671914 Kalkhoran et al. Sep 1997 A
5724986 Jones et al. Mar 1998 A
5726440 Kalkhoran et al. Mar 1998 A
D393830 Tobler et al. Apr 1998 S
5743262 Lepper, Jr. et al. Apr 1998 A
5747806 Khalil et al. May 1998 A
5750994 Schlager May 1998 A
5758644 Diab et al. Jun 1998 A
5760910 Lepper, Jr. et al. Jun 1998 A
5890929 Mills et al. Apr 1999 A
5919134 Diab Jul 1999 A
5987343 Kinast Nov 1999 A
5997343 Mills et al. Dec 1999 A
6002952 Diab et al. Dec 1999 A
6010937 Karam et al. Jan 2000 A
6027452 Flaherty et al. Feb 2000 A
6040578 Malin et al. Mar 2000 A
6066204 Haven May 2000 A
6115673 Malin et al. Sep 2000 A
6124597 Shehada et al. Sep 2000 A
6128521 Marro et al. Oct 2000 A
6129675 Jay Oct 2000 A
6144868 Parker Nov 2000 A
6152754 Gerhardt et al. Nov 2000 A
6184521 Coffin, IV et al. Feb 2001 B1
6232609 Snyder et al. May 2001 B1
6241683 Macklem et al. Jun 2001 B1
6255708 Sudharsanan et al. Jul 2001 B1
6280381 Malin et al. Aug 2001 B1
6285896 Tobler et al. Sep 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6317627 Ennen et al. Nov 2001 B1
6321100 Parker Nov 2001 B1
6334065 Al-Ali et al. Dec 2001 B1
6358058 Strupat Mar 2002 B1
6360114 Diab et al. Mar 2002 B1
6368283 Xu et al. Apr 2002 B1
6411373 Garside et al. Jun 2002 B1
6415167 Blank et al. Jul 2002 B1
6430437 Marro Aug 2002 B1
6430525 Weber et al. Aug 2002 B1
6463311 Diab Oct 2002 B1
6470199 Kopotic et al. Oct 2002 B1
6487429 Hockersmith et al. Nov 2002 B2
6505059 Kollias et al. Jan 2003 B1
6525386 Mills et al. Feb 2003 B1
6526300 Kiani et al. Feb 2003 B1
6534012 Hazen et al. Mar 2003 B1
6542764 Al-Ali et al. Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6584336 Ali et al. Jun 2003 B1
6587196 Stippick et al. Jul 2003 B1
6587199 Luu Jul 2003 B1
6595316 Cybulski et al. Jul 2003 B2
6597932 Tian et al. Jul 2003 B2
6606511 Ali et al. Aug 2003 B1
6635559 Greenwald et al. Oct 2003 B2
6639668 Trepagnier Oct 2003 B1
6640116 Diab Oct 2003 B2
6640117 Makarewicz et al. Oct 2003 B2
6658276 Kiani et al. Dec 2003 B2
6661161 Lanzo et al. Dec 2003 B1
6697656 Al-Ali Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
RE38476 Diab et al. Mar 2004 E
RE38492 Diab et al. Apr 2004 E
6738652 Mattu et al. May 2004 B2
6760607 Al-Ali Jul 2004 B2
6788965 Ruchti et al. Sep 2004 B2
6816241 Grubisic Nov 2004 B2
6822564 Al-Ali Nov 2004 B2
6850787 Weber et al. Feb 2005 B2
6850788 Al-Ali Feb 2005 B2
6876931 Lorenz et al. Apr 2005 B2
6920345 Al-Ali et al. Jul 2005 B2
6934570 Kiani et al. Aug 2005 B2
6943348 Coffin, IV Sep 2005 B1
6956649 Acosta et al. Oct 2005 B2
6961598 Diab Nov 2005 B2
6970792 Diab Nov 2005 B1
6985764 Mason et al. Jan 2006 B2
6990364 Ruchti et al. Jan 2006 B2
6998247 Monfre et al. Feb 2006 B2
7003338 Weber et al. Feb 2006 B2
7015451 Dalke et al. Mar 2006 B2
7027849 Al-Ali Apr 2006 B2
D526719 Richie, Jr. et al. Aug 2006 S
7096052 Mason et al. Aug 2006 B2
7096054 Abdul-Hafiz et al. Aug 2006 B2
D529616 Deros et al. Oct 2006 S
7133710 Acosta et al. Nov 2006 B2
7142901 Kiani et al. Nov 2006 B2
7225006 Al-Ali et al. May 2007 B2
RE39672 Shehada et al. Jun 2007 E
7254429 Schurman et al. Aug 2007 B2
7254431 Al-Ali et al. Aug 2007 B2
7254434 Schulz et al. Aug 2007 B2
7274955 Kiani et al. Sep 2007 B2
D554263 Al-Ali et al. Oct 2007 S
7280858 Al-Ali et al. Oct 2007 B2
7289835 Mansfield et al. Oct 2007 B2
7292883 De Felice et al. Nov 2007 B2
7341559 Schulz et al. Mar 2008 B2
7343186 Lamego et al. Mar 2008 B2
D566282 Al-Ali et al. Apr 2008 S
7356365 Schurman Apr 2008 B2
7371981 Abdul-Hafiz May 2008 B2
7373193 Al-Ali et al. May 2008 B2
7377794 Al-Ali et al. May 2008 B2
7395158 Monfre et al. Jul 2008 B2
7415297 Al-Ali et al. Aug 2008 B2
7438683 Al-Ali et al. Oct 2008 B2
7483729 Al-Ali et al. Jan 2009 B2
D587657 Al-Ali et al. Mar 2009 S
7500950 Al-Ali et al. Mar 2009 B2
7509494 Al-Ali Mar 2009 B2
7510849 Schurman et al. Mar 2009 B2
7514725 Wojtczuk et al. Apr 2009 B2
7519406 Blank et al. Apr 2009 B2
D592507 Wachman et al. May 2009 S
7530942 Diab May 2009 B1
7593230 Abul-Haj et al. Sep 2009 B2
7596398 Al-Ali et al. Sep 2009 B2
7606608 Blank et al. Oct 2009 B2
7620674 Ruchti et al. Nov 2009 B2
D606659 Kiani et al. Dec 2009 S
7629039 Eckerbom et al. Dec 2009 B2
7640140 Ruchti et al. Dec 2009 B2
7647083 Al-Ali et al. Jan 2010 B2
D609193 Al-Ali et al. Feb 2010 S
D614305 Al-Ali et al. Apr 2010 S
7697966 Monfre et al. Apr 2010 B2
7698105 Ruchti et al. Apr 2010 B2
RE41317 Parker May 2010 E
RE41333 Blank et al. May 2010 E
7729733 Al-Ali et al. Jun 2010 B2
7761127 Al-Ali et al. Jul 2010 B2
7764982 Dalke et al. Jul 2010 B2
D621516 Kiani et al. Aug 2010 S
7791155 Diab Sep 2010 B2
RE41912 Parker Nov 2010 E
7880626 Al-Ali et al. Feb 2011 B2
7909772 Popov et al. Mar 2011 B2
7919713 Al-Ali et al. Apr 2011 B2
7937128 Al-Ali May 2011 B2
7937129 Mason et al. May 2011 B2
7941199 Kiani May 2011 B2
7957780 Lamego et al. Jun 2011 B2
7962188 Kiani et al. Jun 2011 B2
7976472 Kiani Jul 2011 B2
7990382 Kiani Aug 2011 B2
8008088 Bellott et al. Aug 2011 B2
RE42753 Kiani-Azarbayjany et al. Sep 2011 E
8028701 Al-Ali et al. Oct 2011 B2
8048040 Kiani Nov 2011 B2
8050728 Al-Ali et al. Nov 2011 B2
RE43169 Parker Feb 2012 E
8118620 Al-Ali et al. Feb 2012 B2
8130105 Al-Ali et al. Mar 2012 B2
8182443 Kiani May 2012 B1
8190223 Al-Ali et al. May 2012 B2
8203438 Kiani et al. Jun 2012 B2
8203704 Merritt et al. Jun 2012 B2
8219172 Schurman et al. Jul 2012 B2
8224411 Al-Ali et al. Jul 2012 B2
8229532 Davis Jul 2012 B2
8233955 Al-Ali et al. Jul 2012 B2
8255026 Al-Ali Aug 2012 B1
8265723 McHale et al. Sep 2012 B1
8274360 Sampath et al. Sep 2012 B2
8280473 Al-Ali Oct 2012 B2
8315683 Al-Ali et al. Nov 2012 B2
RE43860 Parker Dec 2012 E
8346330 Lamego Jan 2013 B2
8353842 Al-Ali et al. Jan 2013 B2
8355766 MacNeish, III et al. Jan 2013 B2
8374665 Lamego Feb 2013 B2
8388353 Kiani et al. Mar 2013 B2
8401602 Kiani Mar 2013 B2
8414499 Al-Ali et al. Apr 2013 B2
8418524 Al-Ali Apr 2013 B2
8428967 Olsen et al. Apr 2013 B2
8430817 Al-Ali et al. Apr 2013 B1
8437825 Dalvi et al. May 2013 B2
8455290 Siskavich Jun 2013 B2
8457707 Kiani Jun 2013 B2
8471713 Poeze et al. Jun 2013 B2
8473020 Kiani et al. Jun 2013 B2
8509867 Workman et al. Aug 2013 B2
8515509 Bruinsma et al. Aug 2013 B2
8523781 Al-Ali Sep 2013 B2
D692145 Al-Ali et al. Oct 2013 S
8571617 Reichgott et al. Oct 2013 B2
8571618 Lamego et al. Oct 2013 B1
8571619 Al-Ali et al. Oct 2013 B2
8577431 Lamego et al. Nov 2013 B2
8584345 Al-Ali et al. Nov 2013 B2
8588880 Abdul-Hafiz et al. Nov 2013 B2
8630691 Lamego et al. Jan 2014 B2
8641631 Sierra et al. Feb 2014 B2
8652060 Al-Ali Feb 2014 B2
8666468 Al-Ali Mar 2014 B1
8670811 O'Reilly Mar 2014 B2
RE44823 Parker Apr 2014 E
RE44875 Kiani et al. Apr 2014 E
8688183 Bruinsma et al. Apr 2014 B2
8690799 Telfort et al. Apr 2014 B2
8702627 Telfort et al. Apr 2014 B2
8712494 MacNeish, III et al. Apr 2014 B1
8715206 Telfort et al. May 2014 B2
8723677 Kiani May 2014 B1
8740792 Kiani et al. Jun 2014 B1
8755535 Telfort et al. Jun 2014 B2
8755872 Marinow Jun 2014 B1
8764671 Kiani Jul 2014 B2
8768423 Shakespeare et al. Jul 2014 B2
8771204 Telfort et al. Jul 2014 B2
8781544 Al-Ali et al. Jul 2014 B2
8790268 Al-Ali Jul 2014 B2
8801613 Al-Ali et al. Aug 2014 B2
8821397 Al-Ali et al. Sep 2014 B2
8821415 Al-Ali et al. Sep 2014 B2
8830449 Lamego et al. Sep 2014 B1
8840549 Al-Ali et al. Sep 2014 B2
8852094 Al-Ali et al. Oct 2014 B2
8852994 Wojtczuk et al. Oct 2014 B2
8897847 Al-Ali Nov 2014 B2
8911377 Al-Ali Dec 2014 B2
8989831 Al-Ali et al. Mar 2015 B2
8998809 Kiani Apr 2015 B2
9066666 Kiani Jun 2015 B2
9066680 Al-Ali et al. Jun 2015 B1
9095316 Welch et al. Aug 2015 B2
9106038 Telfort et al. Aug 2015 B2
9107625 Telfort et al. Aug 2015 B2
9131881 Diab et al. Sep 2015 B2
9138180 Coverston et al. Sep 2015 B1
9153112 Kiani et al. Oct 2015 B1
9192329 Al-Ali Nov 2015 B2
9192351 Telfort et al. Nov 2015 B1
9195385 Al-Ali et al. Nov 2015 B2
9211095 Al-Ali Dec 2015 B1
9218454 Kiani et al. Dec 2015 B2
9245668 Vo et al. Jan 2016 B1
9267572 Barker et al. Feb 2016 B2
9277880 Poeze et al. Mar 2016 B2
9307928 Al-Ali et al. Apr 2016 B1
9323894 Kiani Apr 2016 B2
D755392 Hwang et al. May 2016 S
9326712 Kiani May 2016 B1
9392945 Al-Ali et al. Jul 2016 B2
9408542 Kinast et al. Aug 2016 B1
9436645 Al-Ali et al. Sep 2016 B2
9445759 Lamego et al. Sep 2016 B1
9474474 Lamego et al. Oct 2016 B2
9480435 Olsen Nov 2016 B2
9510779 Poeze et al. Dec 2016 B2
9517024 Kiani et al. Dec 2016 B2
9532722 Lamego et al. Jan 2017 B2
9560996 Kiani Feb 2017 B2
9579039 Jansen et al. Feb 2017 B2
9622692 Lamego et al. Apr 2017 B2
D788312 Al-Ali et al. May 2017 S
9649054 Lamego et al. May 2017 B2
9697928 Al-Ali et al. Jul 2017 B2
9717458 Lamego et al. Aug 2017 B2
9724016 Al-Ali et al. Aug 2017 B1
9724024 Al-Ali Aug 2017 B2
9724025 Kiani et al. Aug 2017 B1
9749232 Sampath et al. Aug 2017 B2
9750442 Olsen Sep 2017 B2
9750461 Telfort Sep 2017 B1
9775545 Al-Ali et al. Oct 2017 B2
9778079 Al-Ali et al. Oct 2017 B1
9782077 Lamego et al. Oct 2017 B2
9787568 Lamego et al. Oct 2017 B2
9808188 Perea et al. Nov 2017 B1
9839379 Al-Ali et al. Dec 2017 B2
9839381 Weber et al. Dec 2017 B1
9847749 Kiani et al. Dec 2017 B2
9848800 Lee et al. Dec 2017 B1
9861298 Eckerbom et al. Jan 2018 B2
9861305 Weber et al. Jan 2018 B1
9877650 Muhsin et al. Jan 2018 B2
9891079 Dalvi Feb 2018 B2
9924897 Abdul-Hafiz Mar 2018 B1
9936917 Poeze et al. Apr 2018 B2
9955937 Telfort May 2018 B2
9965946 Al-Ali et al. May 2018 B2
D820865 Muhsin et al. Jun 2018 S
9986952 Dalvi et al. Jun 2018 B2
D822215 Al-Ali et al. Jul 2018 S
D822216 Barker et al. Jul 2018 S
10010276 Al-Ali et al. Jul 2018 B2
10086138 Novak, Jr. Oct 2018 B1
10111591 Dyell et al. Oct 2018 B2
D833624 DeJong et al. Nov 2018 S
10123729 Dyell et al. Nov 2018 B2
D835282 Barker et al. Dec 2018 S
D835283 Barker et al. Dec 2018 S
D835284 Barker et al. Dec 2018 S
D835285 Barker et al. Dec 2018 S
10149616 Al-Ali et al. Dec 2018 B2
10154815 Al-Ali et al. Dec 2018 B2
10159412 Lamego et al. Dec 2018 B2
10188348 Al-Ali et al. Jan 2019 B2
RE47218 Al-Ali Feb 2019 E
RE47244 Kiani et al. Feb 2019 E
RE47249 Kiani et al. Feb 2019 E
10205291 Scruggs et al. Feb 2019 B2
10226187 Al-Ali et al. Mar 2019 B2
10231657 Al-Ali et al. Mar 2019 B2
10231670 Blank et al. Mar 2019 B2
RE47353 Kiani et al. Apr 2019 E
10279247 Kiani May 2019 B2
10292664 Al-Ali May 2019 B2
10299720 Brown et al. May 2019 B2
10327337 Schmidt et al. Jun 2019 B2
10327713 Barker et al. Jun 2019 B2
10332630 Al-Ali Jun 2019 B2
10383520 Wojtczuk et al. Aug 2019 B2
10383527 Ai-Ali Aug 2019 B2
10388120 Muhsin et al. Aug 2019 B2
D864120 Forrest et al. Oct 2019 S
10441181 Telfort et al. Oct 2019 B1
10441196 Eckerbom et al. Oct 2019 B2
10448844 Al-Ali et al. Oct 2019 B2
10448871 Al-Ali et al. Oct 2019 B2
10456038 Lamego et al. Oct 2019 B2
10463340 Telfort et al. Nov 2019 B2
10471159 Lapotko et al. Nov 2019 B1
10505311 Al-Ali et al. Dec 2019 B2
10524738 Olsen Jan 2020 B2
10532174 Al-Ali Jan 2020 B2
10537285 Shreim et al. Jan 2020 B2
10542903 Al-Ali et al. Jan 2020 B2
10555678 Dalvi et al. Feb 2020 B2
10568553 O'Neil et al. Feb 2020 B2
RE47882 Al-Ali Mar 2020 E
10608817 Haider et al. Mar 2020 B2
D880477 Forrest et al. Apr 2020 S
10617302 Al-Ali et al. Apr 2020 B2
10617335 Al-Ali et al. Apr 2020 B2
10637181 Al-Ali et al. Apr 2020 B2
D887548 Abdul-Hafiz et al. Jun 2020 S
D887549 Abdul-Hafiz et al. Jun 2020 S
10667764 Ahmed et al. Jun 2020 B2
D890708 Forrest et al. Jul 2020 S
10721785 Al-Ali Jul 2020 B2
10736518 Al-Ali et al. Aug 2020 B2
10750984 Pauley et al. Aug 2020 B2
D897098 Al-Ali Sep 2020 S
10779098 Iswanto et al. Sep 2020 B2
10827961 Iyengar et al. Nov 2020 B1
10828007 Telfort et al. Nov 2020 B1
10832818 Muhsin et al. Nov 2020 B2
10849554 Shreim et al. Dec 2020 B2
10856750 Indorf Dec 2020 B2
D906970 Forrest et al. Jan 2021 S
10918281 Al-Ali et al. Feb 2021 B2
10932705 Muhsin et al. Mar 2021 B2
10932729 Kiani et al. Mar 2021 B2
10939878 Kiani et al. Mar 2021 B2
10956950 Al-Ali et al. Mar 2021 B2
D916135 Indorf et al. Apr 2021 S
D917550 Indorf et al. Apr 2021 S
D917564 Indorf et al. Apr 2021 S
D917704 Al-Ali et al. Apr 2021 S
10987066 Chandran et al. Apr 2021 B2
10991135 Al-Ali et al. Apr 2021 B2
D919094 Al-Ali et al. May 2021 S
D919100 Al-Ali et al. May 2021 S
11006867 Al-Ali May 2021 B2
D921202 Al-Ali et al. Jun 2021 S
11024064 Muhsin et al. Jun 2021 B2
11026604 Chen et al. Jun 2021 B2
D925597 Chandran et al. Jul 2021 S
D927699 Al-Ali et al. Aug 2021 S
11076777 Lee et al. Aug 2021 B2
11114188 Poeze et al. Sep 2021 B2
D933232 Al-Ali et al. Oct 2021 S
11145408 Sampath et al. Oct 2021 B2
11147518 Al-Ali et al. Oct 2021 B1
11185262 Al-Ali et al. Nov 2021 B2
11191484 Kiani et al. Dec 2021 B2
20010034477 Mansfield et al. Oct 2001 A1
20010039483 Brand et al. Nov 2001 A1
20020010401 Bushmakin et al. Jan 2002 A1
20020058864 Mansfield et al. May 2002 A1
20020133080 Apruzzese et al. Sep 2002 A1
20030013975 Kiani Jan 2003 A1
20030018243 Gerhardt et al. Jan 2003 A1
20030144582 Cohen et al. Jul 2003 A1
20030156288 Barnum et al. Aug 2003 A1
20030212312 Coffin, IV et al. Nov 2003 A1
20040106163 Workman, Jr. et al. Jun 2004 A1
20050055276 Kiani et al. Mar 2005 A1
20050234317 Kiani Oct 2005 A1
20060073719 Kiani Apr 2006 A1
20060189871 Al-Ali et al. Aug 2006 A1
20070073116 Kiani et al. Mar 2007 A1
20070180140 Welch et al. Aug 2007 A1
20070239058 Krasilchikov et al. Oct 2007 A1
20070244377 Cozad et al. Oct 2007 A1
20080064965 Jay et al. Mar 2008 A1
20080094228 Welch et al. Apr 2008 A1
20080221418 Al-Ali et al. Sep 2008 A1
20090036759 Ault et al. Feb 2009 A1
20090093687 Telfort et al. Apr 2009 A1
20090095926 MacNeish, III Apr 2009 A1
20090247984 Lamego et al. Oct 2009 A1
20100004518 Vo et al. Jan 2010 A1
20100030040 Poeze et al. Feb 2010 A1
20100099964 O'Reilly et al. Apr 2010 A1
20100234718 Sampath et al. Sep 2010 A1
20100270257 Wachman et al. Oct 2010 A1
20110028806 Merritt et al. Feb 2011 A1
20110028809 Goodman Feb 2011 A1
20110040197 Welch et al. Feb 2011 A1
20110082711 Poeze et al. Apr 2011 A1
20110087081 Kiani et al. Apr 2011 A1
20110118561 Tari et al. May 2011 A1
20110120455 Murphy May 2011 A1
20110137297 Kiani et al. Jun 2011 A1
20110172498 Olsen et al. Jul 2011 A1
20110180067 Avni Jul 2011 A1
20110230733 Al-Ali Sep 2011 A1
20120123231 O'Reilly May 2012 A1
20120165629 Merritt et al. Jun 2012 A1
20120209084 Olsen et al. Aug 2012 A1
20120226117 Lamego et al. Sep 2012 A1
20120283524 Kiani et al. Nov 2012 A1
20130023775 Lamego et al. Jan 2013 A1
20130041591 Lamego Feb 2013 A1
20130060147 Welch et al. Mar 2013 A1
20130096405 Garfio Apr 2013 A1
20130296672 O'Neil et al. Nov 2013 A1
20130345921 Al-Ali et al. Dec 2013 A1
20140166076 Kiani et al. Jun 2014 A1
20140180160 Brown et al. Jun 2014 A1
20140187973 Brown et al. Jul 2014 A1
20140275871 Lamego et al. Sep 2014 A1
20140275872 Merritt et al. Sep 2014 A1
20140316217 Purdon et al. Oct 2014 A1
20140316218 Purdon et al. Oct 2014 A1
20140323897 Brown et al. Oct 2014 A1
20140323898 Purdon et al. Oct 2014 A1
20150005600 Blank et al. Jan 2015 A1
20150011907 Purdon et al. Jan 2015 A1
20150073241 Lamego Mar 2015 A1
20150080754 Purdon et al. Mar 2015 A1
20150099950 Al-Ali et al. Apr 2015 A1
20150273165 Hadash Oct 2015 A1
20160196388 Lamego Jul 2016 A1
20160283665 Sampath et al. Sep 2016 A1
20160367173 Dalvi et al. Dec 2016 A1
20170024748 Haider Jan 2017 A1
20170173632 Al-Ali Jun 2017 A1
20170251974 Shreim et al. Sep 2017 A1
20170311891 Kiani et al. Nov 2017 A1
20180242926 Muhsin et al. Aug 2018 A1
20180247353 Al-Ali et al. Aug 2018 A1
20180247712 Muhsin et al. Aug 2018 A1
20180256087 Al-Ali et al. Sep 2018 A1
20180310823 Al-Ali et al. Nov 2018 A1
20190046079 Reed Feb 2019 A1
20190117070 Muhsin et al. Apr 2019 A1
20190239787 Pauley et al. Aug 2019 A1
20190320906 Olsen Oct 2019 A1
20190374713 Kiani et al. Dec 2019 A1
20200060869 Telfort et al. Feb 2020 A1
20200111552 Ahmed Apr 2020 A1
20200113435 Muhsin Apr 2020 A1
20200113488 Al-Ali et al. Apr 2020 A1
20200113496 Scruggs et al. Apr 2020 A1
20200113497 Triman et al. Apr 2020 A1
20200113520 Abdul-Hafiz et al. Apr 2020 A1
20200138288 Al-Ali et al. May 2020 A1
20200138368 Kiani et al. May 2020 A1
20200163597 Dalvi et al. May 2020 A1
20200196877 Vo et al. Jun 2020 A1
20200253474 Muhsin et al. Aug 2020 A1
20200253544 Belur Nagaraj et al. Aug 2020 A1
20200268990 Ash Aug 2020 A1
20200275841 Telfort et al. Sep 2020 A1
20200288983 Telfort et al. Sep 2020 A1
20200321793 Al-Ali et al. Oct 2020 A1
20200329983 Al-Ali et al. Oct 2020 A1
20200329984 Al-Ali et al. Oct 2020 A1
20200329993 Al-Ali et al. Oct 2020 A1
20200330037 Al-Ali et al. Oct 2020 A1
20210022628 Telfort et al. Jan 2021 A1
20210104173 Pauley et al. Apr 2021 A1
20210113121 Diab et al. Apr 2021 A1
20210117525 Kiani et al. Apr 2021 A1
20210118581 Kiani et al. Apr 2021 A1
20210121582 Krishnamani et al. Apr 2021 A1
20210146079 Alizoti May 2021 A1
20210161465 Barker et al. Jun 2021 A1
20210236729 Kiani et al. Aug 2021 A1
20210256267 Ranasinghe et al. Aug 2021 A1
20210256835 Ranasinghe et al. Aug 2021 A1
20210275101 Vo et al. Sep 2021 A1
20210290060 Ahmed Sep 2021 A1
20210290072 Forrest Sep 2021 A1
20210290080 Ahmed Sep 2021 A1
20210290120 Al-Ali Sep 2021 A1
20210290177 Novak, Jr. Sep 2021 A1
20210290184 Ahmed Sep 2021 A1
20210296008 Novak, Jr. Sep 2021 A1
20210330228 Olsen et al. Oct 2021 A1
20210386382 Olsen et al. Dec 2021 A1
Foreign Referenced Citations (3)
Number Date Country
WO 2017141033 Aug 2017 WO
WO-2021194880 Sep 2021 WO
WO 2021262877 Dec 2021 WO
Non-Patent Literature Citations (1)
Entry
International Search Report and Written Opinion received in PCT Application No. PCT/US2021/038733 dated Oct. 20, 2021.
Related Publications (1)
Number Date Country
20210402110 A1 Dec 2021 US
Provisional Applications (2)
Number Date Country
63071310 Aug 2020 US
63044269 Jun 2020 US